drugset / Trial / NCT03502889

Single Dose Adductor Canal Block vs SPANK Block for TKA

NCT03502889 ↗

RandomizedParallel-groupOpen-labelTreatment

Summary

This is a prospective, randomized control trial to compare SPANK block combined with adductor canal block to adductor canal block alone in treatment of post-operative pain after total knee arthroplasty. The primary outcome is pain control, which will be measured throughout the post-operative course using morphine equivalents of opioid analgesics used during the first 24 hours after surgery. Secondary outcomes include pain scores recorded at 4, 8, 12, 16, 20, and 24 hours post-operatively, cumulative pain score, incidence of post-operative nausea and vomiting, and extent of motor blockade. The study will aid in answering the question of whether SPANK block is an effective adjunct in preventing pain and decreasing opioid requirement after TKA.

Timeline

Start
2019-06
Primary completion
2020-04
Completion
2020-06

Publications

Drugs

EvaluationDrugModalityDoseRoute
Background Ropivacaine Other / unclassified 0.5 % Other
Background Ropivacaine Other / unclassified 15 ml Other
Background Ropivacaine Other / unclassified 20 ml Other